首页 > 最新文献

The Ewha Medical Journal最新文献

英文 中文
Use of Olive Oil for the Treatment of a Phytobezoar: A Case Report 用橄榄油治疗植物牛黄:一例报告
Pub Date : 2021-07-31 DOI: 10.12771/emj.2021.44.3.89
H. Choi, Yongil Kim
{"title":"Use of Olive Oil for the Treatment of a Phytobezoar: A Case Report","authors":"H. Choi, Yongil Kim","doi":"10.12771/emj.2021.44.3.89","DOIUrl":"https://doi.org/10.12771/emj.2021.44.3.89","url":null,"abstract":"","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125215995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis 多药耐药结核分枝杆菌可能导致肠结核和克罗恩病的鉴别
Pub Date : 2021-07-31 DOI: 10.12771/emj.2021.44.3.93
S. Hong, S. Park, B. Ye, Suk-Kyun Yang
{"title":"Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis","authors":"S. Hong, S. Park, B. Ye, Suk-Kyun Yang","doi":"10.12771/emj.2021.44.3.93","DOIUrl":"https://doi.org/10.12771/emj.2021.44.3.93","url":null,"abstract":"","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126885447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Unusual Case of Vesicoureteral Reflux and Chronic Kidney Disease in a 10-Year-old Boy with Asymptomatic Bacteriuria 膀胱输尿管反流和慢性肾脏疾病的罕见病例在10岁男孩无症状细菌尿
Pub Date : 2021-04-30 DOI: 10.12771/EMJ.2021.44.2.46
Young Choi, Ji Hyen Lee, Jung Won Lee
Primary vesicoureteral reflux is a common genetically determined condition that is associated with varying degrees of renal scarring and represents one of the main causes of chronic kidney disease in children. Usually vesicoureteral reflux is common in urinary tract infection patient under 5 years of age. However, we report a rare case of high-grade vesicoureteral reflux and chronic kidney disease in a 10-year-old boy who was referred to the pediatric department for incidentally detected asymptomatic bacteriuria. Our case demonstrated that high grade vesicoureteral reflux patient with reduced renal function, bladder and bowel dysfunction at presentation is more likely to progress to chronic kidney disease. (Ewha Med J 2021;44(2):46-49)
原发性膀胱输尿管反流是一种常见的由基因决定的疾病,与不同程度的肾脏瘢痕形成有关,是儿童慢性肾脏疾病的主要原因之一。膀胱输尿管反流常见于5岁以下尿路感染患者。然而,我们报告一个罕见的病例高度膀胱输尿管反流和慢性肾脏疾病在一个10岁的男孩谁被转介到儿科偶然发现无症状细菌尿。我们的病例表明,高级别膀胱输尿管反流患者在出现时伴有肾功能下降、膀胱和肠道功能障碍,更有可能发展为慢性肾脏疾病。(梨花医学杂志;2021;44(2):46-49)
{"title":"Unusual Case of Vesicoureteral Reflux and Chronic Kidney Disease in a 10-Year-old Boy with Asymptomatic Bacteriuria","authors":"Young Choi, Ji Hyen Lee, Jung Won Lee","doi":"10.12771/EMJ.2021.44.2.46","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.2.46","url":null,"abstract":"Primary vesicoureteral reflux is a common genetically determined condition that is associated with varying degrees of renal scarring and represents one of the main causes of chronic kidney disease in children. Usually vesicoureteral reflux is common in urinary tract infection patient under 5 years of age. However, we report a rare case of high-grade vesicoureteral reflux and chronic kidney disease in a 10-year-old boy who was referred to the pediatric department for incidentally detected asymptomatic bacteriuria. Our case demonstrated that high grade vesicoureteral reflux patient with reduced renal function, bladder and bowel dysfunction at presentation is more likely to progress to chronic kidney disease. (Ewha Med J 2021;44(2):46-49)","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116268724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active Surveillance of Papillary Thyroid Cancer: Past, Present, and Future 主动监测甲状腺乳头状癌:过去,现在和未来
Pub Date : 2021-04-30 DOI: 10.12771/EMJ.2021.44.2.37
Jong kyu Kim, H. Kwon, W. Lim, B. Moon, N. Paik
Active surveillance (AS) of papillary thyroid microcarcinoma was first suggested by Dr. Akira Miyauchi at Kuma Hospital in 1993. Based on several subsequent evidences, AS was approved by the American Thyroid Association in 2015. AS is no longer an experimental treatment but has become an acceptable standard of care for patients with low-risk thyroid cancers. No molecular markers, such as BRAF mutations, have been identified to predict the prognosis of papillary thyroid cancer. However, future molecular studies may reveal the relationship between genetic mutations and thyroid cancer prognosis. AS involves closely monitoring thyroid cancer over time, instead of immediately treating it with surgery. Patients and medical doctors should consider these two options: observation or surgery. (Ewha Med J 2021;44(2):37-40)
主动监测甲状腺乳头状微癌(AS)是由熊马医院的Akira Miyauchi医生于1993年首次提出的。基于随后的几项证据,AS于2015年被美国甲状腺协会批准。AS不再是一种实验性治疗,而已成为低风险甲状腺癌患者可接受的护理标准。没有分子标记,如BRAF突变,已确定预测甲状腺乳头状癌的预后。然而,未来的分子研究可能会揭示基因突变与甲状腺癌预后之间的关系。AS需要长期密切监测甲状腺癌,而不是立即进行手术治疗。患者和医生应考虑以下两种选择:观察或手术。(梨花医学杂志2021;44(2):37-40)
{"title":"Active Surveillance of Papillary Thyroid Cancer: Past, Present, and Future","authors":"Jong kyu Kim, H. Kwon, W. Lim, B. Moon, N. Paik","doi":"10.12771/EMJ.2021.44.2.37","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.2.37","url":null,"abstract":"Active surveillance (AS) of papillary thyroid microcarcinoma was first suggested by Dr. Akira Miyauchi at Kuma Hospital in 1993. Based on several subsequent evidences, AS was approved by the American Thyroid Association in 2015. AS is no longer an experimental treatment but has become an acceptable standard of care for patients with low-risk thyroid cancers. No molecular markers, such as BRAF mutations, have been identified to predict the prognosis of papillary thyroid cancer. However, future molecular studies may reveal the relationship between genetic mutations and thyroid cancer prognosis. AS involves closely monitoring thyroid cancer over time, instead of immediately treating it with surgery. Patients and medical doctors should consider these two options: observation or surgery. (Ewha Med J 2021;44(2):37-40)","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129534017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Lymphoma of Cervix 宫颈原发性淋巴瘤
Pub Date : 2021-04-30 DOI: 10.12771/EMJ.2021.44.2.41
J. E. Shim, Juhui Kim, Mi Kyung Kim, Y. Kim, Seung Cheol Kim
Lymphomas that originate from the female genital tract are very rare. Primary cervical lymphoma only accounts for less than 1% of all extra-nodal lymphomas. Clinical mani-festations of primary cervical lymphoma can be nonspecific, vaginal bleeding being the most common symptom, and this makes timely diagnosis often difficult. Prognosis and optimal treatment have yet been established due to the rarity of the disease. In this article, a rare case of primary diffuse large B-cell lymphoma of cervix is reported with a review of the available literature. (Ewha Med J 2021;44(2):41-45)
起源于女性生殖道的淋巴瘤非常罕见。原发性宫颈淋巴瘤仅占所有结外淋巴瘤的不到1%。原发性宫颈淋巴瘤的临床表现可能是非特异性的,阴道出血是最常见的症状,这使得及时诊断往往很困难。由于此病罕见,预后和最佳治疗尚未确定。本文报告一例罕见的宫颈原发性弥漫性大b细胞淋巴瘤,并对现有文献进行复习。(梨花医学杂志;2021;44(2):41-45)
{"title":"Primary Lymphoma of Cervix","authors":"J. E. Shim, Juhui Kim, Mi Kyung Kim, Y. Kim, Seung Cheol Kim","doi":"10.12771/EMJ.2021.44.2.41","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.2.41","url":null,"abstract":"Lymphomas that originate from the female genital tract are very rare. Primary cervical lymphoma only accounts for less than 1% of all extra-nodal lymphomas. Clinical mani-festations of primary cervical lymphoma can be nonspecific, vaginal bleeding being the most common symptom, and this makes timely diagnosis often difficult. Prognosis and optimal treatment have yet been established due to the rarity of the disease. In this article, a rare case of primary diffuse large B-cell lymphoma of cervix is reported with a review of the available literature. (Ewha Med J 2021;44(2):41-45)","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132237623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vision of Ewha in the COVID-19 Pandemic Era: A Note from the President 新冠疫情时代梨花女子大学的展望——总统的讲话
Pub Date : 2021-04-30 DOI: 10.12771/EMJ.2021.44.2.34
Eun Mee Kim
{"title":"Vision of Ewha in the COVID-19 Pandemic Era: A Note from the President","authors":"Eun Mee Kim","doi":"10.12771/EMJ.2021.44.2.34","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.2.34","url":null,"abstract":"","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126907748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Publication Ethics Part 1: Authorship 出版伦理第1部分:作者身份
Pub Date : 2021-04-30 DOI: 10.12771/EMJ.2021.44.2.31
R. Lee
{"title":"Publication Ethics Part 1: Authorship","authors":"R. Lee","doi":"10.12771/EMJ.2021.44.2.31","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.2.31","url":null,"abstract":"","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"82 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131937701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between Systolic Blood Pressure and Triglyceride Level in the Uzbekistan Population 乌兹别克斯坦人群收缩压与甘油三酯水平的相关性
Pub Date : 2021-01-31 DOI: 10.12771/EMJ.2021.44.1.19
Bu Yong Kim, Na Yun Bang, Da In Baik, K. Jung, Junbeom Park
Objectives: This study aimed to characteristic the systolic blood pressure (SBP), diastolic pressure, pulse pressure, glucose, creatine, and lipid profile. This study also aimed to investigate the prevalence of hypertension and the relationship between hypertension and the lipid profile in Uzbekistan. Methods: The subjects consisted of 58 Uzbekistan subjects recruited from Ewha Medical Care patients. Blood samples were collected from the patients for the lipid profile and random glucose and creatinine levels. Paired t tests were used for the group means and a chi-square or Fisher’s exact test for categorical variables. A multiple logistic regression analysis was performed. Results: Among the 58 patients constituting the baseline population, hypertension de-veloped in 42 patients. Among them, the triglyceride (TG) level was significantly higher in the hypertension group than normal group (173.19 vs. 127.06 mg/dL, P=0.014). The SBP had a positive correlation with the TG (r=0.979, P<0.01) and creatinine (r=0.002, P<0.05) levels and also, the pulse pressure had a positive correlation with the cholesterol level (r=0.539, P<0.05). A multivariate analysis (adjusted for age and sex) indicated that there was a positive correlation between the SBP and TG level (r=0.941, P<0.05). Conclusion: There was a positive correlation between the SBP and TG level in the Uzbekistan population according to this study. (Ewha Med J 2021;44(1):19-25)
目的:本研究旨在确定收缩压(SBP)、舒张压、脉压、葡萄糖、肌酸和脂质特征。本研究还旨在调查乌兹别克斯坦的高血压患病率以及高血压与血脂的关系。方法:研究对象为从梨花女子医院患者中招募的58名乌兹别克斯坦人。采集患者的血液样本,测定血脂、随机葡萄糖和肌酐水平。对组均值采用配对t检验,对分类变量采用卡方检验或Fisher精确检验。进行多元逻辑回归分析。结果:在构成基线人群的58例患者中,42例患者发生高血压。其中,高血压组甘油三酯(TG)水平显著高于正常组(173.19 vs. 127.06 mg/dL, P=0.014)。收缩压与TG (r=0.979, P<0.01)、肌酐(r=0.002, P<0.05)呈正相关,脉压与胆固醇(r=0.539, P<0.05)呈正相关。多因素分析(调整年龄和性别)显示收缩压与TG水平呈正相关(r=0.941, P<0.05)。结论:根据本研究,乌兹别克斯坦人群的收缩压与TG水平呈正相关。(梨花医学杂志;2021;44(1):19-25)
{"title":"Correlation between Systolic Blood Pressure and Triglyceride Level in the Uzbekistan Population","authors":"Bu Yong Kim, Na Yun Bang, Da In Baik, K. Jung, Junbeom Park","doi":"10.12771/EMJ.2021.44.1.19","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.1.19","url":null,"abstract":"Objectives: This study aimed to characteristic the systolic blood pressure (SBP), diastolic pressure, pulse pressure, glucose, creatine, and lipid profile. This study also aimed to investigate the prevalence of hypertension and the relationship between hypertension and the lipid profile in Uzbekistan. Methods: The subjects consisted of 58 Uzbekistan subjects recruited from Ewha Medical Care patients. Blood samples were collected from the patients for the lipid profile and random glucose and creatinine levels. Paired t tests were used for the group means and a chi-square or Fisher’s exact test for categorical variables. A multiple logistic regression analysis was performed. Results: Among the 58 patients constituting the baseline population, hypertension de-veloped in 42 patients. Among them, the triglyceride (TG) level was significantly higher in the hypertension group than normal group (173.19 vs. 127.06 mg/dL, P=0.014). The SBP had a positive correlation with the TG (r=0.979, P<0.01) and creatinine (r=0.002, P<0.05) levels and also, the pulse pressure had a positive correlation with the cholesterol level (r=0.539, P<0.05). A multivariate analysis (adjusted for age and sex) indicated that there was a positive correlation between the SBP and TG level (r=0.941, P<0.05). Conclusion: There was a positive correlation between the SBP and TG level in the Uzbekistan population according to this study. (Ewha Med J 2021;44(1):19-25)","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125273706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Molecular Targeted Therapy of Metastatic Colorectal Cancer 转移性结直肠癌的新分子靶向治疗
Pub Date : 2021-01-31 DOI: 10.12771/EMJ.2021.44.1.11
J. Jo
Over the past decade, substantial advances have been made in the individualization of therapeutic strategies for metastatic colorectal cancer (mCRC). Treatment strategies have been developed and classified according to their molecular and genetic character-istics based on predictive biomarkers such as microsatellite instability, RAS and BRAF mutations, HER2 amplification, or NTRK fusions. As molecular and genetic predictive tests are routinely performed, new challenges for mCRC treatment strategies are al-lowed. For patients responding to anti-epithelial growth factor receptor treatments, expanded biomarkers panels enable customized treatment to be selected and the optimal treatment can be determined. Patients with mCRC with the BRAF V600E mutation who did not have effective targeted treatments have effective therapeutic options. Attractive but rare targets, such as HER2 amplification and NTRK fusions, could be a breakthrough and the use of immune checkpoint inhibitors in patients with mismatch repair deficiency/microsatellite instability is the striking revolution. In this review, we summarize the current landscape of targeted therapies for mCRC patients, with a focus on new developments for epithelial growth factor receptor blockade and emerging biomarkers. (Ewha Med J 2021;44(1):11-18)
在过去的十年中,转移性结直肠癌(mCRC)的个体化治疗策略取得了实质性进展。基于预测性生物标志物,如微卫星不稳定性、RAS和BRAF突变、HER2扩增或NTRK融合,治疗策略已根据其分子和遗传特征进行了开发和分类。随着分子和基因预测测试的常规实施,mCRC治疗策略面临新的挑战。对于对抗上皮生长因子受体治疗有反应的患者,扩大的生物标志物面板可以选择定制治疗并确定最佳治疗。没有有效靶向治疗的BRAF V600E突变的mCRC患者有有效的治疗选择。有吸引力但罕见的靶点,如HER2扩增和NTRK融合,可能是一个突破,在错配修复缺陷/微卫星不稳定患者中使用免疫检查点抑制剂是一场引人注目的革命。在这篇综述中,我们总结了mCRC患者靶向治疗的现状,重点介绍了上皮生长因子受体阻断和新兴生物标志物的新进展。(梨花医学杂志;2021;44(1):11-18)
{"title":"New Molecular Targeted Therapy of Metastatic Colorectal Cancer","authors":"J. Jo","doi":"10.12771/EMJ.2021.44.1.11","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.1.11","url":null,"abstract":"Over the past decade, substantial advances have been made in the individualization of therapeutic strategies for metastatic colorectal cancer (mCRC). Treatment strategies have been developed and classified according to their molecular and genetic character-istics based on predictive biomarkers such as microsatellite instability, RAS and BRAF mutations, HER2 amplification, or NTRK fusions. As molecular and genetic predictive tests are routinely performed, new challenges for mCRC treatment strategies are al-lowed. For patients responding to anti-epithelial growth factor receptor treatments, expanded biomarkers panels enable customized treatment to be selected and the optimal treatment can be determined. Patients with mCRC with the BRAF V600E mutation who did not have effective targeted treatments have effective therapeutic options. Attractive but rare targets, such as HER2 amplification and NTRK fusions, could be a breakthrough and the use of immune checkpoint inhibitors in patients with mismatch repair deficiency/microsatellite instability is the striking revolution. In this review, we summarize the current landscape of targeted therapies for mCRC patients, with a focus on new developments for epithelial growth factor receptor blockade and emerging biomarkers. (Ewha Med J 2021;44(1):11-18)","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127165239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Laboratory Diagnosis of COVID-19 in Korea 国内新冠肺炎的实验室诊断
Pub Date : 2021-01-31 DOI: 10.12771/EMJ.2021.44.1.1
Kyunghoon Lee
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is a type of human coronavirus that causes severe pneumonia, similar to SARS-CoV-1 and Middle East respiratory syndrome coronavirus In Korea, the SARS-CoV-2 testing has started quickly from February 2020 to respond to the COVID-19 pandemic In this article, I would like to introduce the characteristics of coronavirus and PCR test methods that play a large role in COVID-19 quarantine measures Real-time reverse transcription (RT)-PCR is one of the molecular diagnostic method, and it detect SARS-CoV-2 RNA by amplifying SARS-CoV-2 specific RdRp (RNA-dependent RNA polymerase) gene and E (envelope) gene at the same time Real-time RT-PCR is currently the most reliable test that confirming COVID-19 and is in use worldwide Real-time RT-PCR test is recommended for COVID-19 confirmatory diagnosis in Korea, but this test requires dedicated equipment, reagents, experienced technicians and laboratory medicine specialists, and it takes about a few hours to a day to report Rapid molecular testing results in one to two hours with a simple procedure Antigen test is less sensitive than real-time RT-PCR and can only be used as a secondary role of diagnosis As the global COVID-19 pandemic progresses, diagnostic testing guidelines and recommendations may vary and will be updated as scientific evidence and experience of the COVID-19 accumulates
2019冠状病毒病(COVID-19)的病因-严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)是一种引起严重肺炎的人类冠状病毒,类似于SARS-CoV-1和中东呼吸综合征冠状病毒。在韩国,为应对COVID-19大流行,从2020年2月开始迅速开始了SARS-CoV-2检测。我想介绍冠状病毒的特点和在COVID-19检疫措施中发挥重要作用的PCR检测方法。实时反转录(RT)-PCR是分子诊断方法之一,通过扩增SARS-CoV-2特异性RNA聚合酶(RdRp)基因和E (envelope)基因,同时检测SARS-CoV-2 RNA。实时实时RT-PCR是目前世界范围内使用的最可靠的确诊方法,在国内推荐使用实时实时RT-PCR进行确诊,但需要专用设备和试剂,需要经验丰富的技术人员和检验医学专家。抗原检测的敏感性不如实时RT-PCR,只能作为诊断的次要作用。随着全球COVID-19大流行的进展,诊断检测指南和建议可能会有所不同,并将随着COVID-19科学证据和经验的积累而更新
{"title":"Laboratory Diagnosis of COVID-19 in Korea","authors":"Kyunghoon Lee","doi":"10.12771/EMJ.2021.44.1.1","DOIUrl":"https://doi.org/10.12771/EMJ.2021.44.1.1","url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is a type of human coronavirus that causes severe pneumonia, similar to SARS-CoV-1 and Middle East respiratory syndrome coronavirus In Korea, the SARS-CoV-2 testing has started quickly from February 2020 to respond to the COVID-19 pandemic In this article, I would like to introduce the characteristics of coronavirus and PCR test methods that play a large role in COVID-19 quarantine measures Real-time reverse transcription (RT)-PCR is one of the molecular diagnostic method, and it detect SARS-CoV-2 RNA by amplifying SARS-CoV-2 specific RdRp (RNA-dependent RNA polymerase) gene and E (envelope) gene at the same time Real-time RT-PCR is currently the most reliable test that confirming COVID-19 and is in use worldwide Real-time RT-PCR test is recommended for COVID-19 confirmatory diagnosis in Korea, but this test requires dedicated equipment, reagents, experienced technicians and laboratory medicine specialists, and it takes about a few hours to a day to report Rapid molecular testing results in one to two hours with a simple procedure Antigen test is less sensitive than real-time RT-PCR and can only be used as a secondary role of diagnosis As the global COVID-19 pandemic progresses, diagnostic testing guidelines and recommendations may vary and will be updated as scientific evidence and experience of the COVID-19 accumulates","PeriodicalId":197820,"journal":{"name":"The Ewha Medical Journal","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131398139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
期刊
The Ewha Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1